KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.
The US private equity firm is looking to hire financial advisers to help evaluate a sale of its 53.8% stake in the Mumbai-based company, the people said, asking not to be identified as the matter is private. Other buyout firms and industry players have shown preliminary interest in buying KKR’s stake, the people said.
Shares of the company, which is known as JB Pharma, have climbed 68% in the past 12 months, valuing the firm at just over $3 billion.
Can’t stop reading? Read more
Ares raises $5.4bn for US and Europe real estate strategies as recovery drives demand
Ares raises $5.4bn for US and Europe real estate strategies as recovery drives demand Ares has...
Blue Owl caps fund withdrawals as private credit demand recalibrates amid market volatility
Blue Owl caps fund withdrawals as private credit demand recalibrates amid market volatility Blue...
Sycamore targets $4bn profit at Walgreens following $10bn buyout
Sycamore targets $4bn profit at Walgreens following $10bn buyout Sycamore Partners is targeting a...